Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

StemGenex® Offers New Options to Diabetes Patients through Cutting-Edge Stem Cell Therapy

BIOGY

StemGenex is now providing access to the latest stem cell treatment options for patients diagnosed with Diabetes. These treatments are being studied with expertise by board certified MD's in the United States.

LA JOLLA, Calif., Jan. 7, 2014 /PRNewswire/ -- According to The American Diabetes Association there are over 25 million people in the US living with diabetes.  These patients are suffering from complications such as heart disease, stroke, high blood pressure, blindness, kidney disease, neuropathy and amputation. Since adult stem cells have the ability to differentiate into many different types of cells, such as those required for proper pancreatic functioning, StemGenex® believes there is hope for these patients.

www.StemGenex.com

StemGenex® is currently studying ways to regenerate insulin producing cells within the pancreas by using adult stem cells.  By harvesting adipose derived stem cells through a mini-liposuction procedure, the doctors can then minimally manipulate the stem cells in an on-site lab before reintroducing them back into the patient's body, the very same day.  Once the stem cells are reintroduced, StemGenex believes they may differentiate into insulin producing cells of the pancreas.  StemGenex is studying outcomes such as better glycemic control, decreases in insulin requirement, as well as reductions in HBA1C and triglyceride levels.

Stem cell treatment studies are currently being offered by StemGenex to patients diagnosed with Diabetes as well as degenerative neurological diseases. StemGenex takes a unique approach of compassion and empowerment while providing access to the latest stem cell therapies for diseases including Parkinson's, Alzheimer's, Diabetes, stroke recovery, COPD and others. Rita Alexander, founder of StemGenex and the company's first stem cell patient, insists that all patients be treated like they are one of our loved ones. "Hope, compassion, and the relentless pursuit for an end to these diseases are our primary focus."

StemGenex® is extremely proud of its reputation as a leader in the stem cell industry as well as its dedication to putting patients first.  StemGenex actively tracks and posts its patient satisfaction rates on its website in multiple categories as a way to share with the public how patients have been positively affected through these stem cell studies.  These statistics are updated monthly and can be found here: StemGenex Patient Satisfaction Ratings

To find out more about stem cell therapy, contact StemGenex either by phone at (800) 609-7795 or email Contact@stemgenex.com.

www.StemGenex.com

 

www.StemGenex.com

Image with caption: "www.StemGenex.com". Image available at: http://photos.prnewswire.com/prnh/20140107/LA41524-a

Image with caption: "www.StemGenex.com". Image available at: http://photos.prnewswire.com/prnh/20140107/LA41524-b

Image with caption: "www.StemGenex.com". Image available at: http://photos.prnewswire.com/prnh/20140107/LA41524-c

SOURCE StemGenex

Tags:


Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today